Caller alleging discrepant inratio values.(b)(6) 2015 inratio 6.5 lab 7.2, (b)(6) 2015 inratio 3.3 lab 4.1, (b)(6) 2015 inratio 2.2 lab 1.8, (b)(6) 2015 inratio 2.2 lab 1.6.Thirty minutes between tests on all days.Patient's therapeutic range 2-3.Per doctor's request, patient discontinued coumadin on 04/13/2015 to prep for surgery.Doctors found patient had severe toe infection and was given 1500 mg of unspecified antibiotics for several days which elevated his inr.The doctor wanted the inr to be down to a 1.3 for surgery.The inr remained above the recommended level, therefore, the coumadin was resumed on (b)(6) 2015 and surgery will be performed at a later date.Though requested, no additional information available.No reported adverse patient sequela.No additional information provided.
|
Investigation/conclusion update:
it is indicated that the product is not returning for evaluation.Since the product associated with the complaint was not returned, a review of in-house testing was performed.Retain strip testing results met both accuracy and strip repeatability criteria.The product performed as expected and no product deficiencies were observed.A review of the manufacturing records for the lot did not uncover any relevant non-conformances.The lot meets release specification.Root cause is unable to be determined from the information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|